Most cited papers from Slotervaartziekenhuis

Slotervaartziekenhuis

What are the most cited papers from Slotervaartziekenhuis?

The most cited paper from Slotervaartziekenhuis is "Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs" (Alfred H. Schinkel, Jasper Smit, Olaf van Tellingen et al., 1994), with 2,298 citations. Next come "Disseminated Intravascular Coagulation" (2,005) and "Identification of a new human coronavirus" (1,938).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 281 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Alfred H. Schinkel, Jasper Smit, Olaf van Tellingen et al. · Cell	May 1994	2,298
2	Disseminated Intravascular Coagulation Marcel M Levi, Hugo Ten Cate · New England Journal of Medicine	19 Aug 1999	2,005
3	Identification of a new human coronavirus Lia van der Hoek, Krzysztof Pyrć, Maarten F. Jebbink et al. · Nature Medicine Open access	21 Mar 2004	1,938
4	Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial Yvonne P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart et al. · Arthritis & Rheumatism Open access	28 Oct 2005	1,466
5	Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids Krijn K. Dijkstra et al. · Cell Open access	9 Aug 2018	1,129
6	Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home Maria M.W. Koopman, Paolo Prandoni, Franco Piovella et al. · New England Journal of Medicine Open access	14 Mar 1996	1,118
7	Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis Dees PM Brandjes, Harry Roger Buller, Harriët Heijboer et al. · The Lancet Open access	Mar 1997	875
8	Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1 Ara Koh, Antonio Molinaro, Marcus Ståhlman et al. · Cell Open access	25 Oct 2018	847
9	Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial Evelien de Jong et al. · The Lancet Infectious Diseases Open access	2 Mar 2016	847
10	A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Dick Pluim et al. · Clinical Cancer Research Open access	Jun 2004	831
11	The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria Johan W. Jonker, Marije Buitelaar, Els Wagenaar et al. · Proceedings of the National Academy of Sciences Open access	12 Nov 2002	824
12	Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis Thomas P. C. Dorlo, Manica Balasegaram, Jos H. Beijnen et al. · Journal of Antimicrobial Chemotherapy	24 Jul 2012	784
13	Atrophic Gastritis andHelicobacter pyloriInfection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication Ernst Johan Kuipers, Lars R. Lundell, Elly C. Klinkenberg–Knol et al. · New England Journal of Medicine Open access	18 Apr 1996	778
14	Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies Ron J. Keizer, Alwin D. R. Huitema, Jan H.M. Schellens et al. · Clinical Pharmacokinetics	8 Jul 2010	728
15	Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus Bernhard Kleter, Leen‐Jan van Doorn, Lianne Schrauwen et al. · Journal of Clinical Microbiology Open access	Aug 1999	665
16	Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review Marije Emilie Hamaker, J.M. Jonker, Sophia E de Rooij et al. · The Lancet Oncology Review	28 Sep 2012	647
17	Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan Johan W. Jonker · JNCI Journal of the National Cancer Institute	18 Oct 2000	640
18	Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Sanne B. Schagen, Frits S.A.M. van Dam, Martin J. Muller et al. · Cancer Open access	Feb 1999	630
19	Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Ellen Stokvis, Hilde Rosing, Jos H. Beijnen · Rapid Communications in Mass Spectrometry	12 Jan 2005	589
20	Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors Kimberley M. Heinhuis, Willeke Ros, Marleen Kok et al. · Annals of Oncology Open access	3 Jan 2019	575
21	Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review Bernd‐Jan Sanson, Anthonie W.A. Lensing, Martin M.H. Prins et al. · Thrombosis and Haemostasis	1999	555
22	Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer Ramón Salazar, Paul Roepman, Gabriel Capellá et al. · Journal of Clinical Oncology	23 Nov 2010	545
23	Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa Elly C. Klinkenberg–Knol, Frits G. Nelis, John Dent et al. · Gastroenterology Open access	Apr 2000	545
24	Effect of Periodontal Treatment on Glycemic Control of Diabetic Patients Wijnand J. Teeuw, Victor E. A. Gerdes, Bruno G. Loos · Diabetes Care Open access	26 Jan 2010	526
25	A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Giuseppe Giaccone, Cornelis J. A. Punt, Yoshitaka Ando et al. · PubMed	Dec 2002	507
26	Converting a breast cancer microarray signature into a high-throughput diagnostic test Annuska M. Glas, Arno N. Floore, Leonie J. M. J. Delahaye et al. · BMC Genomics Open access	30 Oct 2006	497
27	Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein Thrombosis Dees P. M. Brandjes, Harriët Heijboer, Harry Roger Buller et al. · New England Journal of Medicine Open access	19 Nov 1992	485
28	Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis Gertjan Wolbink, Marijn Vis, Willem F. Lems et al. · Arthritis & Rheumatism	28 Feb 2006	472
29	Clinical Pharmacokinetics of Cyclophosphamide Milly E. de Jonge, Alwin D. R. Huitema, Sjoerd Rodenhuis et al. · Clinical Pharmacokinetics	2005	453
30	Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein Jan Wijnholds, Raymond Evers, Manuel R. van Leusden et al. · Nature Medicine	Nov 1997	440
31	Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety Elly C. Klinkenberg–Knol, Henk P. M. Festen, Jan B. M. J. Jansen et al. · Annals of Internal Medicine	Aug 1994	430
32	The influence of prehospital time on trauma patients outcome: A systematic review Annelieke M. K. Harmsen, Georgios Fredericus Giannakopoulos, Patrick R. Moerbeek et al. · Injury Review	16 Jan 2015	429
33	Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis Mike J. L. Peters, Irene Eva van der Horst-Bruinsma, Ben A. C. Dijkmans et al. · Seminars in Arthritis and Rheumatism Open access	Dec 2004	383
34	Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy Suzanne Leijen, Sjaak A. Burgers, Paul Baas et al. · Investigational New Drugs Open access	24 Oct 2014	371
35	Operative Treatment of Spontaneous Spinal Epidural Hematomas: A Study of the Factors Determining Postoperative Outcome Rob J. M. Groen, H. August M. van Alphen · Neurosurgery	Sep 1996	359
36	Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta‐analysis Wijnand J. Teeuw, Dagmar Else Slot, Hendri Murti Susanto et al. · Journal Of Clinical Periodontology Review	12 Oct 2013	354
37	Upfront Genotyping of DPYD2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis Maarten J. Deenen, Didier Meulendijks, Annemieke Cats et al. · Journal of Clinical Oncology* Open access	17 Nov 2015	352
38	Prevalence of Human Papillomavirus DNA in Different Histological Subtypes of Cervical Adenocarcinoma Edyta Catalina Pirog, Bernhard Kleter, Semra Olgac et al. · American Journal Of Pathology Open access	Oct 2000	345
39	The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial Willeke F. Westendorp et al. · The Lancet Open access	19 Jan 2015	339
40	Piraña and PCluster: A modeling environment and cluster infrastructure for NONMEM Ron J. Keizer, Michel van Benten, Jos H. Beijnen et al. · Computer Methods and Programs in Biomedicine	3 Jun 2010	334
41	Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis Lidewine Daniels et al. · British journal of surgery Open access	30 Sep 2016	329
42	Total Ankle Arthroplasty in Inflammatory Joint Disease with Use of Two Mobile-Bearing Designs H. Cornelis Doets, Ronald Brand, Rob G. H. H. Nelissen · Journal of Bone and Joint Surgery	Jun 2006	326
43	Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs Pauline Breedveld, Jos H. Beijnen, Jan H.M. Schellens · Trends in Pharmacological Sciences Review	6 Dec 2005	325
44	Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance Suman Rijal, Bart Ostyn, Surendra Kumar Uranw et al. · Clinical Infectious Diseases	20 Feb 2013	323
45	ENDOTOXAEMIA: AN EARLY PREDICTOR OF SEPTICAEMIA IN FEBRILE PATIENTS SanderJ.H. Van Deventer, JanW. Ten Gate, HarryR. Buller et al. · The Lancet	Mar 1988	319
46	Review: Viral infections and mechanisms of thrombosis and bleeding Marco Goeijenbier, Matthijs Van Wissen, C. van de Weg et al. · Journal of Medical Virology Open access	15 Aug 2012	314
47	Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids Jeanine M.L. Roodhart, Laura G.M. Daenen, Edwin C.A. Stigter et al. · Cancer Cell Open access	Sep 2011	309
48	Breast cancer in pregnancy: Recommendations of an international consensus meeting Frédéric Amant et al. · European Journal of Cancer	7 Oct 2010	308
49	The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients Angelique C.M. Jansen, E. S. van Aalst‐Cohen, Michael W.T. Tanck et al. · Journal of Internal Medicine Open access	19 Nov 2004	303
50	Concise Drug Review: Azacitidine and Decitabine Ellen J. B. Derissen, Jos H. Beijnen, Jan H.M. Schellens · The Oncologist Open access	May 2013	302

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.